214 related articles for article (PubMed ID: 3498791)
1. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.
Ranges GE; Figari IS; Espevik T; Palladino MA
J Exp Med; 1987 Oct; 166(4):991-8. PubMed ID: 3498791
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.
Espevik T; Figari IS; Ranges GE; Palladino MA
J Immunol; 1988 Apr; 140(7):2312-6. PubMed ID: 3280680
[TBL] [Abstract][Full Text] [Related]
4. Insight into the mechanism(s) through which TNF promotes the generation of T cell-mediated antitumor cytotoxicity by tumor bearer splenic cells.
Gorelik L; Bar-Dagan Y; Mokyr MB
J Immunol; 1996 Jun; 156(11):4298-308. PubMed ID: 8666801
[TBL] [Abstract][Full Text] [Related]
5. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
[TBL] [Abstract][Full Text] [Related]
6. TGF beta down-regulates TLiSA1 expression and inhibits the differentiation of precursor lymphocytes into CTL and LAK cells.
Jin B; Scott JL; Vadas MA; Burns GF
Immunology; 1989 Apr; 66(4):570-6. PubMed ID: 2541074
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state.
Tada T; Ohzeki S; Utsumi K; Takiuchi H; Muramatsu M; Li XF; Shimizu J; Fujiwara H; Hamaoka T
J Immunol; 1991 Feb; 146(3):1077-82. PubMed ID: 1671050
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cytolytic T lymphocyte maturation with ornithine, arginine, and putrescine.
Susskind BM; Chandrasekaran J
J Immunol; 1987 Aug; 139(3):905-12. PubMed ID: 2955052
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta 1 (TGF-beta 1) inhibit the expression and activity of Na+/K(+)-ATPase in FRTL-5 rat thyroid cells.
Pekary AE; Levin SR; Johnson DG; Berg L; Hershman JM
J Interferon Cytokine Res; 1997 Apr; 17(4):185-95. PubMed ID: 9142647
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice.
Fontana A; Frei K; Bodmer S; Hofer E; Schreier MH; Palladino MA; Zinkernagel RM
J Immunol; 1989 Nov; 143(10):3230-4. PubMed ID: 2809199
[TBL] [Abstract][Full Text] [Related]
11. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
Hiserodt JC
J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.
Espevik T; Figari IS; Shalaby MR; Lackides GA; Lewis GD; Shepard HM; Palladino MA
J Exp Med; 1987 Aug; 166(2):571-6. PubMed ID: 3110354
[TBL] [Abstract][Full Text] [Related]
13. Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression.
Kalinichenko VV; Mokyr MB; Graf LH; Cohen RL; Chambers DA
J Immunol; 1999 Sep; 163(5):2492-9. PubMed ID: 10452985
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta 1 enhances the suppression of human hematopoiesis by tumor necrosis factor-alpha or recombinant interferon-alpha.
Sing GK; Keller JR; Ellingsworth LR; Ruscetti FW
J Cell Biochem; 1989 Feb; 39(2):107-15. PubMed ID: 2715197
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta 1 enhances the generation of allospecific cytotoxic T lymphocytes.
Kondo S; Isobe K; Ishiguro N; Nakashima I; Miura T
Immunology; 1993 Jul; 79(3):459-64. PubMed ID: 8406573
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
Lin JY; Seguin R; Keller K; Chadee K
Immunology; 1995 Jul; 85(3):400-7. PubMed ID: 7558128
[TBL] [Abstract][Full Text] [Related]
18. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1.
Wallick SC; Figari IS; Morris RE; Levinson AD; Palladino MA
J Exp Med; 1990 Dec; 172(6):1777-84. PubMed ID: 2258706
[TBL] [Abstract][Full Text] [Related]
20. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells.
Okada M; Kitahara M; Kishimoto S; Matsuda T; Hirano T; Kishimoto T
J Immunol; 1988 Sep; 141(5):1543-9. PubMed ID: 3261754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
